ArticleThe Lancet. Oncology2023
Distant metastasis-free survival with adjuvant pembrolizumab for resected stage IIB or IIC melanoma.
Dun-Chang Mo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleThe Lancet. Oncology2023
Dun-Chang Mo et al.PubMed ↗Publisher ↗
No numbers read from the abstract.